MaaT Pharma SA (EPA: MAAT)
France
· Delayed Price · Currency is EUR 8.30
+0.14 (1.72%)
Nov 19, 2024, 5:35 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €114.69 million as of November 21, 2024. Its market cap has increased by 25.37% in one year.
Market Cap
114.69M
Enterprise Value
100.71M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€8.30
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 114.69M, a decrease of -13.59%. That is a compound annual growth rate of -4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 114.69M | 41.60% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 114.34B |
| EssilorLuxottica Société anonyme | 106.74B |
| Sartorius Stedim Biotech S.A. | 16.33B |
| bioMérieux S.A. | 11.56B |
| Ipsen S.A. | 8.81B |
| Eurofins Scientific SE | 8.62B |
| Virbac SA | 2.68B |
| Ramsay Générale de Santé SA | 1.32B |